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ABSTRACT 
 
 
Cancer is the second leading cause of death in the United States after heart disease. 
Because the frequency of cancer diagnoses is correlated with life expectancy, we can 
expect the rate of cancer diagnosis to increase with the increase of life expectancy. 
Additionally, cancer treatments are notoriously costly and challenging due to the 
heterogeneity of the cancer cell population. For these reasons, devising methods to study 
the characteristics, efficiently diagnose and treat cancer is extremely important. 
 
Warburg effect has been considered as the most unique mechanism that differ cancer 
cells from normal cells. Normally, most of the healthy cells predominantly produce 
energy by a low rate of glycolysis and oxidation of pyruvate in mitochondria, called 
oxidative phosphorylation. In the 1920s, Otto Warburg observed that tumors uptake a 
massive amount of glucose compared to its surrounding healthy tissues. Additionally, 
glycolysis was continued even in the presence of oxygen, called aerobic glycolysis. 
Cancer cells trend to metabolize excessive uptake of glucose and ferment to lactate 
unlike normal cells, even in the presence of oxygen and fully functioning mitochondria. 
This high rate of aerobic glycolysis in cancer cells is known as Warburg effect, which 
has been studied extensively especially after 2000s. Cancer cells have an unusually high 
rate of glycolysis and subsequently lactic acid fermentation to produce energy for cell 
activities, even under aerobic conditions, a seemingly inefficient way of producing 
energy. 
 
It is recognized that cancer tumors undergo acidification due to the Warburg effect and 
 
 
the overexpression of carbonic anhydrase enzymes at the surfaces of cancer cells, 
making acidity a universal tumor characteristic, and following the micro calories 
exchange during glycolytic fermentation. The more invasive the cancer is, the greater 
the extra-cellular acidosis and heat production.  
 
The pH (Low) Insertion Peptides comprise a novel class of pH-sensitive targeting agents 
that spontaneously insert into cell membranes under acidic conditions. Therefore, the 
applicability of pHLIP® peptides to tumor-targeting applications is an obvious choice 
for investigation, it could be reconstructed with many different types of imaging and 
therapeutic agents. The membrane associated folding mechanism of action of pHLIP is 
triggered by low pH. The high concentration of proton in the low pH environment 
increase the protonation of the protonatable residues in pHLIP, which increase the 
overall hydrophobicity and drives the peptide into the hydrophobic core of the 
membrane, where it forms transmembrane helix. The two terminus of the peptide, one 
stays in the extracellular space while the other one pass through the membrane and 
locates into the cytoplasm. 
 
With the creation of SNARF-pHLIP® construct in this work, it will allow me to measure 
the extra-cellular pH at the surface on the membrane of individual cancer cells. This will 
provide an advantage over measuring the bulk extra-cellular pH since it will result in 
higher contrast between normal, metastatic and non-metastatic cells, furthermore this 
novel construct could help with cancer diagnosing. I will apply it to metastatic and non-
metastatic cancer cell lines. This will showcase that non-metastatic and metastatic cells 
can be distinguished from each other quickly and easily by their individual surface pHs. 
 
 
 
Enhanced permeability and retention (EPR) effect is how most of the approved 
nanomedicinal products work though for cancer imaging and therapy. However, the 
heterogenous of cancers made them impossible to universally target. Extracellular 
acidity has been identified as a common property of cancerous cells, hence we can apply 
pHLIP® as a novel agent to coat noisome, making it has a high uptake near cancer cells.
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PREFACE 
This dissertation is written in “Manuscript” format, using the Thesis/Dissertation 
template of the University of Rhode Island. There are three manuscripts included in this 
dissertation, each of which comprises a chapter. The tables and figures of each 
manuscript are listed under the corresponding chapter in the list of tables and figures. 
 
The results of our studies presented in the last chapters were published in the following 
papers: 
1. Pereira MC, Pianella M, Wei D, Moshnikova A, Marianecci C, Carafa M, 
Andreev OA & Reshetnyak YK. “pH-sensitive pHLIP® coated niosomes.” 
(2017) Mol Membr Biol. doi:10.1080/09687688.2017.1342969. 
 
The first chapter is composed of research that has been submitted for publication in 
Molecular Imaging and Biology: 
3. Wei D, Engelman DM, Reshetnyak YK and Andreev OA “Mapping of Acidity 
at Cancer Cells Surfaces.” Manuscript submitted for publication. 
 
We are still working on collecting data and analysis for the second chapter, the results are 
in the hypothesis direction, it will be continued and published in the future. 
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ABSTRACT 
 
Solid tumors have an acidic extracellular environment, which results from the elevated 
glycolytic activity of cancer cells. Cancer cells maintain neutral intracellular pH (7.2) 
by transporting out protons and lactate acid. Acidity of extracellular microenvironment 
in tumor, and particularly near the cancer cells surface, is high. To validate this 
assumption, we recently introduced a novel approach of extracellular pH measurements 
at the surface of cells by using a pH-sensitive fluorescent dye, SNARF, conjugated to a 
pH Low Insertion Peptide (pHLIP® peptide), which targets plasma membranes of cells 
in acidic diseased tissue. Our original approach was based on measurements of 
fluorescence spectra of SNARF pHLIP. Here we present a novel pH mapping method, 
which allows measurements of pH of individual cells with high spatial resolution. Novel 
approach is based on the analysis of two fluorescent images of SNARF pHLIP formed 
by dual view optical system where one image is recorded using 579±17 nm filter and 
other image using 647±28.5 nm filter. We developed program to align images, find 
ratios between images and convert ratios into pH map for individual cells. An average 
pH for each cell and a pH histogram for all cells within the image are calculated. The 
data obtained on several cancer cell lines grown in spheroids indicate that in absence of 
glucose or in presence of deoxyglucose (non-metabolizable glucose analog) the pH at 
the surface of most cells were similar and close to the pH of bulk solution. While in 
presence of glucose highly metastatic cancer cells have lower surface pH than non-
metastatic cells, and both cells types showed surface pH to be lower than bulk 
extracellular pH. 
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INTRODUCTION 
Otto Warburg discovered that cancer cells predominately use glycolysis for ATP 
production even when oxygen supply is sufficient, and he also found that tumor 
microenvironment is more acidic than that in normal tissues [1]. For many years the 
main tool of measuring pH in tumor tissue was a needle pH meter, which is an invasive 
method that damage cells and could not distinguish between intercellular and 
extracellular pHs [2]. It was believed that intracellular pHi and extracellular pHe were 
both acidic until it was shown that pHi is rather neutral (7.2) in both normal and cancer 
cells, while pHe is an acidic in tumors in contrast to normal pHe found in healthy tissue 
[3-5]. Tumor acidosis is caused mostly by the enhancement of glycolytic metabolism 
and an inhibition of phosphorylation-oxidation pathway of energy production [6, 7]. To 
maintain normal pHi cancer cells have to pump out protons produced during glycolysis 
[8]. Membrane carbonic anhydrases are inducing further cell surface acidification by 
hydrating cell-generated CO2 into HCO3- and H+ at the cancer cell membrane [7]. As 
a result, it is expected that an “acidic layer” will be formed around cancer cells, and 
steep proton concentration gradient might exist near the surface of cancer cells. Thus, 
the cancer cells surface pH is the best measure of tumor acidity.  
 
We recently introduced novel approach for cell surface pH measurements using pH Low 
Insertion Peptide (pHLIP) conjugated with pH sensitive ratiometric fluorescent dye, 
SNARF [9]. pHLIPs can target tumors and deliver imaging and therapeutic agents to 
cancer cells within tumors [10-15]. pHLIPs form transmembrane helix with N-terminus 
pointed outside a cell and C-terminus inserted across membrane. SNARF was 
conjugated to the N-terminus of pHLIP to measure pH near the surface of cancer cells 
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in extracellular space [9]. We used spectroscopic method to record SNARF emission at 
580 nm and 640 nm, calculate ratio and convert it into pH values. However, this 
approach does not allow measuring of pH at a single cell level. Therefore, here we 
present a new pH mapping method to measure pH of individual cells with high spatial 
resolution.     
 
MATERIALS AND METHODS 
Materials 
D-(+)-glucose ≥ 99.5% and 2-deoxy-D-glucose ≥ 99% were purchased from Sigma-
Aldrich. Matrigel® growth factor reduced basement membrane matrix, phenol red-free 
was obtained from Corning. The wild type (WT) pH (Low) Insertion Peptide, WT-
pHLIP, was synthesized with a single Lys residue near its acetylated N-terminus (Ac-
AKEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT) and purified by reverse-
phase chromatography at the C.S.Bio. SNARF™-1 carboxylic acid, acetate, 
succinimidyl ester was purchased from ThermoFisher Scientific.  
 
Phosphate-Buffered Solutions 
Phosphate-buffered solutions were prepared to obtain the pH range of 6.0-8.0 by mixing 
0.5 M dibasic and monobasic solutions (J. T. Baker). The final experimental PBS 
solution contained 10 mM phosphate, 150 mM NaCl (J. T. Baker), 0.2 mM MgCl2 
(Sigma), and 0.2 mM CaCl2 (Sigma). Buffer solutions were sterilized by passage 
through a 0.2-µm filter. The final pH for each solution was measured by dual star pH / 
ISE benchtop meter with a microelectrode (Thermo Scientific™ Orion™). 
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Synthesis of SNARF-pHLIP  
Lys-WT and SNARF-1 were dissolved in DMF (dimethylformamide, Sigma), and 
incubated at a ratio of 2:1 in 60% DMF (dimethylformamide), 30% 0.1 M PBS pH 9.0 
and 10% pH 9.5 0.1 M sodium bicarbonate buffer for a final pH of 9.0. SNARF-1 was 
converted to its fluorescent form after conjugation by raising the conjugation solution’s 
volume by 50% with methanol and raising the solution pH to 14 with 2 M potassium 
hydroxide for 1 hour. Then, pH was adjusted to pH 7.0 by adding 30% HCl. The reaction 
progress was monitored by reverse phase (Zorbax SB-C18 columns, 9.4 × 250 mm 5 
μm, Agilent Technology) high-performance liquid chromatography (HPLC) using a 
gradient of 25−75% acetonitrile and water containing 0.05% of trifluoroacetic acid. The 
concentration of each labeled peptide in buffer was determined by SNARF-1 absorption 
at 548 nm, ε548=27,000 M-1 cm−1. The purity and characterization of the construct 
was performed by analytical HPLC and surface-enhanced laser desorption/ionization–
TOF mass spectrometry. 
 
Cell Lines 
Human melanoma M4A4 and NM2C5 cell lines were obtained from the American 
Tissue and Culture Collection (ATCC). Cells were authenticated, stored according to 
supplier’s instructions, and used within 3–4 months after frozen aliquots resuscitations. 
All lines were cultured in Dulbecco’s modified Eagle medium (DMEM) containing 4.5 
g/L glucose and 40 mg/L sodium pyruvate supplemented with 10% FBS (Gibco), 0.1% 
of 10 µg/mL ciprofloxacin⋅HCl (Cellgro, Voigt Global Distribution) in a humidified 
atmosphere of 5% CO2 at 37 °C. 
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Tumor Spheroids 
A 2% agarose (Sigma) solution was made by dissolving in pH 7.4 PBS (Gibco). 150 µL 
of the solution was pipetted into each well of a 48-well flat bottom tissue culture plate 
(Celltreat). After the agarose gel had sufficiently settled (∼1 h), 150 µL of DMEM 
supplemented with 10% FBS and ciprofloxacin⋅HCl was added to each well. The 
covered plate was left in a humidified atmosphere at 37°C and 5% CO2 in cell culture 
incubator for 24 h. Next day, the excess media was removed from the agarose layer. 
NM2C5 or M4A4 cells, 10,000 cells, in 200 µL of DMEM contains 2% matrigel 
(Corning) were added into each well and kept in cell culture incubator for 3-4 days to 
allow formation of spheroids. Matrigel was dissolved on ice overnight and added in ice 
cold DMEM at a concentration of 2.5% (to obtain final 2% once added to the wells). 
Then the mixture was heated to 37°C before being combined with cells. 
 
Imaging Tumor Spheroids  
Tumor spheroids of a given cell line were incubated in 50 μL of PBS buffer, pH6.3 
containing 5 μM SNARF-pHLIP and either 25 mM glucose or 50 mM deoxyglucose in 
a humidified atmosphere of 5% CO2 at 37°C for 30 min. After treatment the spheroids 
were washed three times in 1 mL of experimental PBS of the desired pH containing 
either 25 mM glucose or 50 mM deoxy-glucose for control. Next, the spheroids were 
placed into a 96 wells glass bottom dish for imaging. 
 
The fluorescence images were recorded using Olympus IX71, an inverted 
epifluorescence microscope, using FF01-531/40-25 Semrock excitation filter; a DV2 
multichannel imaging system, with FF01-579/34-25 and FF01-647/57-25 Semrock 
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emission filters in left and right channels, respectively, which allowed two images to be 
taken at the same time by Q-imaging Retiga-SRV CCD.  
 
Data Analysis 
For each pH point, 20 spheroids were used in total: 10 spheroids were used for 
calibration, and 10 spheroids were used for cancer cell surface pH measurements. For 
calibration and pH measurements glucose and deoxy-glucose were added to 5 spheroids, 
respectively. 5 images were taken from different spots of each spheroid. All images 
were analyzed by our program written in Matlab R2016b. The output of analysis 
included a correction curve, pH map and pH histogram for the selected cells in each 
image. Statistical analysis and final graphs were obtained using Origin Lab 2016.  
  
RESULTS 
To measure pH at the surface of cancer cells we used pHLIP conjugated with pH 
sensitive fluorescent dye, SNARF, at the N-terminus of the peptide, which stays 
exposed to the extracellular space after insertion into plasma membrane of cancer cells. 
Previously we demonstrated using quenching of SNARF fluorescence by membrane 
impermeable Trypan Blue that SNARF pHLIP is not taken by endocytosis, and SNARF 
indeed is located in the extracellular space and reports about cell surface pH [9]. 
Fluorescence spectrum of SNARF exhibits two maxima at 580 nm and 640 nm, the ratio 
of intensities of which correlates with pH of microenvironment. The advantage of 
ratiometric method is that it does not depend on concentration of SNARF and allows to 
measure pH with high accuracy. The intensities of two emission maxima can be 
obtained from fluorescence spectrum recorded by linear CCD camera simultaneously in 
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the range of 570 - 700 nm, as it was done in our previous work [9]. The spectroscopic 
method is accurate, however, it measures only an average intensity values from the 
illuminated spot, which includes multiple cells and space between cells [9]. In this work 
we developed pH mapping approach. SNARF fluorescence was excited using 531±20 
nm excitation filter, and emission signal was split into two using DV2 optical system to 
acquire two fluorescent images, where one image was obtained using 579±17 nm 
emission filter (called 580 nm) and the other image is obtained using 647±28.5 nm 
emission filter (called 640 nm). Both images are originated from the same area and 
acquired simultaneously by the same CCD camera, which exclude any influence of 
potential intensity fluctuations on calculated pH values. The interface of image analysis 
program in Matlab is presented on Figure 1. First, correction at a pixel level is applied 
in order to align two selected regions from the image (Figure 1a). The intensity values 
of each pixel at the center (within the region of ±25 pixel units) of the selected 640 nm 
image region are compared with the corresponding central pixels intensity values of 580 
nm image region (Figure 1b). The differences in intensity between 640 nm and 580 nm 
images are shown in Figure 1f. Two images are adjusted to reach minimum of the 
intensity differences and align images for further processing. Intensity (Figure 1c) and 
size (Figure 1d) cutoff were used to establish cell border outline (red outlines in Figure 
1e). The pH mapping is obtained by calculating the averaged intensity ratio for each cell 
and converting these ratios into pH values using calibration curves (Figure 1g). The pH 
histogram reflects distribution of the surface pH for all selected cells (Figure 1h).  
 
The calibration curves were obtained for NM2C5 (Figure 2a) and M4A4 (Figure 2b) 
cancer cells separately. M4A4 or NM2C5 tumor spheroids were incubated in media with 
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no glucose and then transferred into media containing of 50 mM of non-metabolizable 
analog of glucose, deoxyglucose. The inhibition of glycolysis results in shutdown of 
acid production by cells, and flux of protons. As a result, the pH at the surface of cells 
became the same as in the bulk solution, which was used to calibrate fluorescence signal 
with pH. We recorded numerous cells images at different buffer pH and calculated 
580/640 ratio images (RM4A4 and RNM2C5) to establish calibration curves for each 
cancer cell lines (Figure 2a, b): 
 
for M4A4 cells:  𝑝𝐻 = (9.990 ± 0.111) − (5.182 ± 0.190) ∙ 𝑅𝑀4𝐴4 
for NM2C5 cells:  𝑝𝐻 = (10.187 ± 0.100) − (5.257 ± 0.155) ∙ 𝑅𝑁𝑀2𝐶5 
 
The calibrations curves are slightly different for M4A4 and NM2C5 cells, which might 
be attributed to the difference in membrane protein and/or lipid compositions. 
 
The calibration equations were used to calculate surface pH from the SNARF pHLIP 
580/640 nm ratio imaging of non-metastatic cancer cell line, NM2C5, and metastatic 
cancer cell line, aM4A4, in the presence of 25 mM glucose, which promotes cellular 
metabolism. In the presence of glucose, both NM2C5 and M4A4 cells show lower pH 
at the surface compared with the bulk extracellular pH. Furthermore, metastatic cancer 
cells were slightly more acidic than non-metastatic cancer cells, especially when the pH 
of media was normal or higher than pH 7.4. When the pH of media is lower than pH 6.4, 
the pH at the surface of cancer cells equilibrates with bulk solution pH (Figure 2a, b). 
The surface pH differences (difference in pH found in the presence of glucose and 
deoxy-glucose) for each type of cancer cells are shown in Figure 2c. At normal or high 
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pH of media the metastatic cancer cells, M4A4, exhibit a significantly larger pH 
difference, about 0.7 pH units, compared to the non-metastatic cancer cells, NM2C5, 
pH difference of which is about 0.3 pH units (Figure 2d). 
 
Finally, 100x magnification objective was used to image single M4A4 cells in tumor 
spheroids (Figure 3). Instead of calculating the average intensity for cell, we calculated 
the intensity ratios at each pixel inside a single cell to establish pH mapping. The 
obtained results clearly indicate that the surface pH within a single cell is not uniform, 
which might be associated with segregation of proton pumps. 
 
DISCUSSION 
In early days tumor acidity was measured mostly by microelectrodes directly inserted 
into tumor tissue. It was demonstrated that tumors are acidic and it was believed at that 
time that extracellular and intracellular, pHe and pHi, were both acidic [4]. However, 
microelectrodes could not directly measure pH inside of a cell. Only after development 
of magnetic resonance spectroscopy (MRS) methods it was found that pHi in cancer 
cells is similar to or slightly more basic than that in normal cells, while pHe in tumors 
was more acidic than pHe in healthy tissues [3, 5]. MRS methods are using pH sensitive 
agents to measure pHe in tumors in vivo [16]. Those agents are distributed in both blood 
(where pH is normal) and extracellular space. Thus, MRS provides measure of an 
averaged pH in tumors [17-21]. Since cancer cells have to maintain pHi in the range of 
pH 7.2 – 7.4 for normal cellular functions, they have to pump out protons and lactate, 
which are produced in high amounts due to the enhancement of glycolysis [1]. The other 
by-product is CO2, which freely diffuses across membrane and is converted into 
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carbonic acid by membrane proteins, carbonic anhydrases (CAIX, CAXII), 
overexpressed in cancer cells [22-24]. Protons create high acidity zone near the cancer 
cell membrane. pH increases with distance from the cancer cells, and bulk extracellular 
pH might be normal in a well perfused tumor areas, or might remain low in a poorly 
perfused tumor zones. Despite on variations of bulk extracellular pH in tumors 
(documented by MRS measurements) cell surface pH is much more stable parameter, 
which correlates well with metastatic potential of cancer cells. Therefore, it is important 
to develop tools of cell surface pH measurements to investigate tumor development and 
progression. And, it is crucial for pH targeting approaches to sense acidity at the cell 
surface, as pHLIP does, for targeting of imaging and therapeutic agents to all cancer 
cells within tumors. In this work we introduced new method to map cell surface pH at 
the level of individual cancer cells. We believe, the introduced approach can find many 
applications in cancer biology studies, and it might be translated to the clinics for pH 
measurements on tissue samples removed in the course of needle biopsy or surgery. 
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    FIGURES 
 
 
 
 
 
Figure 1. The interface of image analysis program in Matlab is shown. Fluorescence 
580 nm and 640 nm images (a) were obtained using DV2 beam splitting system and 
579±17 nm and 647±28.5 nm emission filters, respectively. The area of interest is 
selected by squares.  Image correction (b), intensity (c) and size cutoff (d) panels of 
interface are presented, which are used to establish cell border outlines shown in red (e). 
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The differences in intensity values in each pixel at the center (within the region of ±25 
pixels) between 640 nm and 580 nm image regions (f) were used to adjust 580 nm image 
position to reach minimum of the intensity differences (achieve the smallest score) and 
align images for further processing. pH map (g), where pH values are indicated by 
different colors, and pH histogram (h) calculated for the selected region from (a). 
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Figure 2. Calibration curves for NM2C5 (a) and M4A4 (b) cells grown in tumor 
spheroids obtained by linear fit of buffer pH vs 580/640 SNARF fluorescence intensity 
ratio in presence of 50 mM deoxy-glucose at various pHs of buffer. Cell surface pH (c) 
measured using SANRF pHLIP in NM2C5 and M4A4 cell spheroids in the presence of 
25 mM glucose at various pHs of buffer were calculated using calibration curves (a and 
b) obtained for each cell line to convert 580/640 nm fluorescence ratios into pH values. 
The cell surface pH differences (d) for non-metastatic NM2C5 and metastatic M4A4 
cancer cells were calculated by comparing pH values obtained in the presence of deoxy-
glucose and glucose at different pHs of buffer. 
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Figure 3. (a) Single cell was selected on the surface of M4A4 tumor spheroids and two 
images were acquired using DV2 system with 580 (left) and 640 (right) nm filters. (b) 
Left and right images were aligned and 580/640 nm intensities ratios were calculated 
for each pixel, the ratios were converted in pH values and presented as pH map with 
color scale shown on the right.  
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Abstract 
 
Warburg effect has been considered as the most unique mechanism that differ cancer 
cells from normal cells. Normally, most of the healthy cells predominantly produce 
energy by a low rate of glycolysis and oxidation of pyruvate in mitochondria, called 
oxidative phosphorylation. In the 1920s, Otto Warburg observed that tumors uptake a 
massive amount of glucose compared to its surrounding healthy tissues. Additionally, 
glycolysis was continued even in the presence of oxygen, called aerobic glycolysis [1, 
2]. Cancer cells trend to metabolize excessive uptake of glucose and ferment to lactate 
unlike normal cells, even in the presence of oxygen and fully functioning mitochondria. 
Cancer cells have an unusually high rate of glycolysis and subsequently lactic acid 
fermentation to produce energy for cell activities, even under aerobic conditions, a 
seemingly inefficient way of producing energy. This high rate of metabolism leads to 
the metabolic chemical reactions and ions directional flows in living cells driven by 
electrochemical potentials and energy-consuming pumping processes, which all 
together would result in the heat production. In this research, we designed experiments 
to measure heat production by cancer cells due to their metabolic activity. From the 
isothermal calorimetry measurements, we estimated that HeLa cells produce about 40 
times more heat per second than regular Chinese Hamster Ovarian cell. From 
intracellular temperature measurements, we also observed that GFP – HeLa incubated 
with glucose has a higher temperature than incubated with deoxy-glucose. 
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Introduction 
 
The metabolic chemical reactions and the various kinds of ions directional flows in 
living cells driven by electrochemical potentials and energy-consuming pumping 
processes is hypothesized to result in the heat production [3, 4]. Steep temperature 
gradients in cells have attracted strong interest from cell biologists recently, especially 
concerning the effects of local intracellular thermogenesis on the rates of chemical 
reactions, the rate of the diffusion process, the speed of exocytosis [5], and so on. The 
peculiarities of energy metabolism in cancer cells are imputable not only to a markedly 
glycolytic phenotype, but also to some essential features, such as a heavy imbalance in 
the NADH/NAD+ ratio with a marked increase of lactate and decrease of pyruvate 
production [6-8]. Temperature is of fundamental importance in many cellular processes 
such as cell metabolism, cell division and gene expression [5, 9, 10]. Accurate and 
noninvasive monitoring of temperature changes in individual cells could thus help 
clarify intricate cellular processes and develop new applications in biology and 
medicine. 
 
In a long history of the physiological studies on thermogenesis, the thermodynamic 
parameters have mainly been examined for different parts of the body, tissues or organs, 
as a whole [5-8]. With the development of new methods and technologies, there are 
appeared some recent studies on thermogenesis at single-cell level. In this part, I will 
introduce the methods that we developed for single cell heat production measurements, 
progresses and some results. 
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Isothermal Titration Calorimeter (ITC) for extracellular heat production 
measurement 
ITC is a technique used in quantitative studies of a wide variety of biomolecular 
interactions. ITC is the only technique that can simultaneously determine all binding 
parameters in a single experiment. A complete thermodynamic profile of the molecular 
interaction, including binding constants (KD), reaction stoichiometry (n), enthalpy (∆H) 
and entropy (ΔS) could be accurately calculated by measuring the heat transfer during 
binding [11]. Not only given binding affinities, ITC is particularly useful as it elucidates 
the mechanisms underlying molecular interactions, which leads to further optimization 
of compounds and more confident decision making [12]. In our research, ITC was used 
to monitor the heat production by cancer cells after injection with glucose or deoxy-
glucose.  
 
ITC has been used to directly measure the heat production that is either released or 
absorbed during a biomolecular binding event. It is composed of two identical cells 
made of a highly efficient thermally conducting and chemically inert material such as 
Hastelloy alloy or gold, surrounded by an adiabatic jacket. One of the cells is called 
reference cell, which is usually filled with buffer or water; the other one is sample cell, 
where the reaction take place when injecting the second component to the sample. The 
microcalorimeter needs to keep these two cells at the same temperature. If there is a 
difference between two cells when binding occurs, the sensor can detect the difference 
in temperature and give feedback to the heaters, the heaters that making direct 
connection with the cells will start compensating until the temperature in the sample cell 
is the same with the reference cell. The heat exchange during the reaction, which is a 
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few millionths of a degree Celsius, will be detected and measured by the output of the 
heater to maintain the temperature balance.  
 
In our ITC experiment, we loaded 5 million HeLa cells that have been starved in the 
medium without glucose overnight into measuring unit, then injected glucose or deoxy-
glucose and monitored the heat exchange for 10 hours. All solutions in this experiment 
were degassed, since it is often necessary to obtain good measurements as the presence 
of gas bubbles within the sample cell will lead to abnormal data plots in the recorded 
results. The entire experiment took place under computer control. As described in 
Figure1, negative heat flow means the reaction is exothermic, the temperature in the 
sample cell increases upon addition of glucose, which lead to the decreases for the 
feedback power to the sample chamber to maintain an equal temperature between the 
two chambers. As the temperature of the two chambers reach equilibrium, the heat flow 
line reached a plateau. The first heat flow spike/pulse at 0 second gives the total heat 
released upon glucose or deoxy-glucose injections, and mixing process. It has been 
observed that a plateau was reached in 1 hour after injection of deoxy-glucose while 
after glucose injection it took about 4 hours. The heat release, which is the integral of 
the curve, also indicates that HeLa has more heat production with glucose injection than 
with deoxy-glucose that. We estimated that single HeLa cell generates about 4 nW, 
which is about 40 times higher than that for regular Chinese Hamster Ovarian cell (0.1 
nW), and 13 times higher than human fibroblasts (0.3 nW). 
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Green Fluorescent Protein (GFP) Anisotropy for intracellular heat production 
measurement 
 
In physics, as opposed to isotropy, anisotropy means inhomogeneity in all directions. It 
is the quality of exhibiting properties being directional dependent, which implies 
different values when measured along axes in different directions. Anisotropy is most 
easily observed in regular lattices, in which atoms, ions, or molecules are arranged 
regularly. Usually these lattices include single crystals of solid elements or compounds 
[13]. In life science, fluorescence anisotropy, which is a population of fluorophores 
illuminated by a linearly polarized light that re-emits partially polarized fluorescence 
due to the random orientation of the molecular dipoles [14]. A strong light source is 
generally required for fluorescence polarization measurements. The light wave coming 
from this source can have an unlimited number of orientations. A polarization filter 
transmits only light of one orientation of electric vector. Fluorophore molecule can be 
considered as a linear oscillator, which would absorb light with a probability 
proportional to cosine of angel between dipole vector and electric vector of excitation 
light and it would emit light with probability of orientation of electric vector 
proportional to the cosine of angel between emitting dipole and electric vector of emitted 
light. Use another polarization filter for emission signal, the strength of the signal 
changes according to the orientation of the emitted light. The emitted light that has the 
same orientation as the polarized excitation filter completely passes the same orientation 
emission polarized filter. The emitted light that is perpendicular to the polarized 
excitation filter is completely blocked by the same filter. The anisotropy r of a light 
source is defined as the ratio of polarized components: 
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𝑟 =  
𝐼𝑧  −  𝐼𝑦
𝐼𝑥  +  𝐼𝑦 +  𝐼𝑧
 
When we use two excitation polarization filters that have the perpendicular orientations, 
one is in the same orientation with the polarized excitation filter, another one is 
perpendicular to it, two polarized intensities that perpendicular to each other could be 
detected. If the excitation polarizer is in z-axis, then the parallel emission from 
fluorophore is symmetric in the same orientation, the perpendicular emission polarizer 
will be in xy- plan. Statistically, we have 𝐼𝑥  =  𝐼𝑦, as 𝐼𝑦  =  𝐼⊥, 𝐼𝑧  =  𝐼⫽ , the anisotropy 
of fluorophore has become: 
𝑟 =  
𝐼⫽  −  𝐼⊥
𝐼⫽  +  2 𝐼⊥
 
To calculate the fluorescence anisotropy, we just need to measure the polarized emission 
intensities that parallel and perpendicular to the polarized excitation light. 
For immobilized randomly oriented dipoles anisotropy of emitted light could be 0.4 if 
emission and excitation dipoles are collinear, and -0.2 if they are perpendicular. 
Fluorophores in solution are very mobile and dipole can rotate during excited state and 
emit at different angel, which leads to depolarization of emitted light. Depolarization of 
fluorescence depends on ratio of rotational correlation time and fluorescence life time. 
Rotational correlation time decreases with increase of temperature while fluorescence 
life time is less sensitive to temperature. The fluorophores, which are molecular level 
particles that suspended in cytoplasm, have molecular rotation [15]. The measured value 
r is closely related to molecular rotation, according to Perrin’s equation: 
1
𝑟
 =  
1
𝑟0
 (1 +  
𝜏𝐹
𝜏𝑅
) 
Where  𝑟0  is a constant called “limiting anisotropy”, 𝜏𝐹  is another constant called 
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fluorescence lifetime and 𝜏𝑅 is rotational correlation time, while 𝜏𝑅 depends on the 
temperature 𝑇, the viscosity 𝜼(𝑇), and the hydrodynamic volume 𝑉 . 𝜏𝐹 does not. 
According to Debye-Stoke-Einstein equation: 
𝜏𝑅  =  
𝑉 𝜼(𝑇)
𝑘𝐵 𝑇
 
Temperature could be measured by using fluorescence anisotropy. When the 
temperature increases, the molecular rotation of the fluorophores is accelerated, they 
move faster in a given amount of time. Faster movement means that the polarization of 
the light is conserved for a shorter time, which means that an increase in temperature 
results in lower polarization signal. Consequently, an increase in temperature leads to a 
decrease of the fluorescence polarization anisotropy. This technique has a lot of 
advantages compare to other methods, the ratiometric measurement is absolute 
intensities independent, common issues like photobleaching and fluorophore migration 
could be eliminated. This method is also noninvasive for cells, which provides more 
accurate and optimistic results.  
 
In our previous study, we constructed optical system and developed the software to 
create and analyze the fluorescence anisotropy images of cells, single molecules and 
nanoparticles. The system includes the inverted microscope (Olympus IX71), two 
calcite prisms (CPs) inserted in the excitation and emission optical paths, and a CCD 
camera (Retiga-SRV, Q-imaging Co.). The excitation light was passed through the 
pinhole diaphragm, split by CP into two orthogonally polarized beams and focused by 
objective into two spots. The emission CP splits the fluorescence image of each spot 
into two images formed by horizontally and vertically polarized emission lights. The 
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CCD camera simultaneously records four images so the fluctuation in intensity of 
excitation light does not affect anisotropy values and, most importantly, that two 
polarized components corresponds exactly to the same state of a sample. We are using 
this system to study the “blinking” effect of quantum dots, binding of fluorescently 
labeled molecules to proteins, DNA, RNA in cells. 
 
In this research, we used a new optical system that almost identical to the cell surface 
pH measurement. Instead of measuring the two excitation peaks from the fluorescent 
dye, SNARF, we are capturing the polarized fluorescent signals at two perpendicular 
directions from green fluorescent protein (GFP). The first direction is parallel to the 
incident polarized light’s direction, the second one is perpendicular to the incident 
polarization. GFP is one of the most widely studied and used proteins that extracted 
from jellyfish, which is a fluorophore that re-emits partially polarized fluorescence due 
to the random orientation of the molecular dipoles. We used GFP transfected HeLa in 
our experiments. Since GFP was expressed in the cytoplasm of HeLa cells, the 
temperature that measured in the experiment would be the local temperature of 
intracellular space. Temperature imaging technique for HeLa – GFP combines high 
spatial resolution and fast read-out with full biocompatibility. 
 
In the optical system, a vertically polarized filter was installed between the microscope 
and the lamp, to turn the incident light into polarized light to the randomly oriented GFP 
inside of the cells, only those molecules that are oriented properly in the polarized plane 
can absorb light, become excited, and subsequently emit polarized light in a plane. On 
the side, the protein fluorescence signal goes into the beam splitter that contains a 
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vertical and a horizontal polarizer on each side, and split the incident beam into two 
identical beams for each side. One beam will pass through the vertically polarized filter, 
which is parallel to the incident light, the intensity is 𝐼⫽. The identical split beam will 
pass through the horizontal polarized filter, which is perpendicular to the incident light, 
this intensity is 𝐼⊥. The signals were recorded by the CCD camera in the same image on 
the right and left side, as a result, the emitted light was measured in both the vertical and 
horizontal planes. To check the orientation of the polarizers, an external polarizer was 
used under bright field with a calibration slide, when the external polarizer was rotated, 
the intensities will change based on the angle between the polarizers. When the external 
polarizer rotates to the vertical orientation, the vertically signal will completely pass the 
filter, while the horizontally signal completely being blocked by the filter (Figure 2), 
indicating the polarizers are in the correct experimental orientation. 
 
G factor is the instrument sensitivity ratio towards vertically and horizontally polarized 
light [16]. In fluorescence anisotropy measurements, the G factor is not related to 
properties of the sample but is purely an experimental correction for the polarization 
bias of the detection system. For accurate measurement, G factor has to be considered 
in the equation.  
𝑟 =  
𝐼⫽  − 𝐺 𝐼⊥
𝐼⫽  +  2 𝐺 𝐼⊥
 
G factor is also measured by exciting the sample using vertically polarized light and 
subsequently measuring the vertically and horizontally polarized components of the 
emission intensity, each for the same period of time. Since there is no difference 
between the numbers of photons coming towards the vertical and horizontal channels 
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from the sample, G factor is calculated as the ratio between the measured total intensities 
in each channel. For anisotropy imaging we need to do correction all image pixels. To 
calculate the G factor, fluorescein was used as correction sample. As the fluorescence 
anisotropy for fluorescein is close to zero due to the complete random orientation of the 
small molecule and very low rotational correlation time (<1 ns), 𝑖⫽ and 𝑖⊥ should be 
equals to each other theoretically, the intensity difference in the two orientations will be 
caused by the optical system. (Figure 3) By measuring 𝑖⫽ and 𝑖⊥, G factor could be 
calculated by 𝐺 =  
𝑖⫽
 𝑖⊥
.  
 
To apply the detection system correction to the samples, the equation can be converted 
to: 
𝑟 =  
𝐼⫽  − 𝐺 𝐼⊥
𝐼⫽  +  2 𝐺 𝐼⊥
=  
𝐼⫽  −
𝑖⫽
 𝑖⊥
 𝐼⊥
𝐼⫽  +  2 
𝑖⫽
 𝑖⊥
 𝐼⊥
=  
𝐼⫽
𝑖⫽
 −
𝐼⊥
 𝑖⊥
 
𝐼⫽
𝑖⫽
 +  2 
𝐼⊥
 𝑖⊥
 
 
Thus, an image calculation for both sides of the image at the same time, cell image 
divided by fluorescein solution image would apply the G factor to the sample (Figure 
4). Once the G factor has been applied to the cell image, the image can be processed by 
the further modified Matlab code for anisotropy imaging. The procedures are identical 
to pH imaging, including load the image, select sections from two sides of the image, 
apply the correction for the selected sections to align the regions, subtract the lowest 
intensity value in the regions as background to the cells, contour the cells based on 
intensity and area cutoff, calculate the fluorescence protein anisotropy for each 
contoured cell, plot anisotropy map and histogram for each image with all the selected 
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cells (Figure 5).  
 
During the experiment, two dishes with 50,000 HeLa-GFP cells were grow in 300uL 
DMEM with high glucose in a collagen coated glass bottom microwell dish for one day, 
the medium was changed to DMEM without glucose to starve the cells overnight in the 
incubator, which is a humidified atmosphere of 5% CO2 and 95% air at 37°C. On the 
third day, cells were washed three times with pH 7.4 PBS contains physiological level 
ions, then stayed in 300uL experimental PBS buffer contains 25Mm glucose, and 
another dish with 50mM deoxy-glucose as comparison. After 30 minutes in room 
temperature to reach temperature equilibrium, the cells in the dishes were used for 
imaging. The fluorescence images were recorded through Olympus IX71, an inverted 
epifluorescence microscope, using a vertical polarization filter and GFP-3035B-OMF-
ZERO Semrock filter set; a DV2 multichannel imaging system, with vertical polarized 
and horizontal polarized filter in left and right channels respectively, which allows 
images that have different information on the two sides taken at the same time by 
Qimaging Retiga-SRV CCD. Fluorescence images of the samples were taken by using 
Q-capture Pro 7. 10, images for each situation was taken and analyzed through Matlab 
2016b. Statistic and result graphs were constructed by Origin Lab 2016. 
 
In the result, anisotropy values were indicated in y axis (Figure 6). There is a clear 
difference of 0.00836 in anisotropy between samples incubated with glucose and deoxy-
glucose. Cells incubated with glucose have a lower anisotropy, indicating that these 
cells have an overall higher temperature. The result is in agreement with what we have 
assumed from the beginning and the result we got from ITC experiment.  
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Since a higher temperature for cancer cells incubated with glucose has been confirmed, 
and the anisotropy difference is 0.00836. What are the temperatures for the cells in each 
case? To determine the temperature, a calibration experiment between measured 
anisotropy and local temperature around cells was performed. The same amount of 
HeLa-GFP were prepared in the same procedures, starved overnight in DMEM without 
glucose and incubated in 3mL PBS with same concentration of deoxy-glucose the next 
day, so it would be possible to measure the buffer temperature in the dish with EXTECH 
EsayViewTM 10 thermometer. The temperature of the sample was controlled by Tokai 
Hit stage top incubator from 20°C to 40°C. Images were taken 20 minutes after the stage 
temperature have reached setting, the local temperature of cells were determined by the 
reading of thermometer for each image. After calculating the anisotropy value in each 
image at different temperatures, an equation of fluorescence protein anisotropy and cell 
temperature will be acquired. Thus, the cell temperature could be determined by 
knowing the anisotropy. The temperature was controlled from 22.5°C to 38.5°C, and 
the measured anisotropy was from 0.23 – 0.15, with a 0.08 anisotropy unit difference. 
An estimation of 1°C corresponds to 0.005 anisotropy unit, thus, the estimated 
temperature difference between cells incubated with glucose and deoxy-glucose is about 
1.6°C. 
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FIGURES 
 
 
Figure 1. Heat production from HeLa cells detected by ITC. The first heat flow 
spike/pulse at 0 second gives the total heat exchanged in the glucose/deoxy-glucose 
injection, which is the heat released when mixing two liquids together. Deoxy-glucose 
injection takes about 1 hour to reach equilibrium and glucose injection takes about 4 
hours. The heat release, which is the integral of the curve, indicating HeLa cells 
release more heat production with glucose injection. 
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Figure 2. Optical system polarization. When the external polarizer rotates to the 
vertical orientation, the vertically signal will completely pass the filter (right side), 
while the horizontally signal completely being blocked by the filter (left side).  
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Figure 3. Fluorescent image of fluorescein as correction to the system. As the fluorescence 
protein anisotropy for fluorescein is zero due to the complete random orientation of the 
molecule. By applying this correction to the images, G factor and the uneven intensity 
distribution from lamp will be eliminated. 
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Figure 4. Processed HeLa-GFP image for anisotropy calculation. The original images were 
devided by the G factor image, and the black regions on the sides were cropped in ImageJ for 
better Matlab processing. Parallel intensity comes from the right side, and perpendicular 
intensity comes from the left side of the image. 
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Figure 5. Image analysis and outputs. a. The interface of image analysis program created by 
Matlab. b. Differences in intensity value between the center of selected perpendicular region 
and ±25 pixels units from the center of selected parallel region. The correction distance was 
applied to the selected parallel region by using the location of smallest score pixel. c. Anisotropy 
map for the selected cells in a., anisotropy values are indicated by different colors for each cell. 
d. Anisotropy histogram for the selected cells in a..
38  
 
 
Figure 6. HeLa-GFP anisotropy result. The anisotropy for HeLa-GFP incubated with glucose 
has a lower value than incubated with deoxy-glucose, indicating that HeLa-GFP has a higher 
temperature with glucose incubation.
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Abstract 
 
Nanomedicine is becoming very popular over conventional methods due to the ability 
to tune physico-chemical properties of nanovectors, which are used for encapsulation 
of therapeutic and diagnostic agents. However, the success of nanomedicine primarily 
relies on how specifically and efficiently nanocarriers can target pathological sites to 
minimize undesirable side effects and enhance therapeutic efficacy. Here, we introduce 
a novel class of targeted nano drug delivery system, which can be used as an effective 
nano-theranostic for cancer. We formulated pH-sensitive niosomes (80-90 nm in 
diameter) using non-ionic surfactants Span20 (43-45 mol%), cholesterol (50 mol%) and 
5 mol% of pH (Low) Insertion Peptide (pHLIP) conjugated with DSPE lipids (DSPE-
pHLIP) or hydrophobic fluorescent dye, pyrene, (Pyr-pHLIP). pHLIP in coating of 
niosomes was used as an acidity sensitive targeting moiety. We have demonstrated that 
pHLIP coated niosomes sense the extracellular acidity of cancerous cells. Intravenous 
injection of fluorescently labeled (R18) pHLIP-coated niosomes into mice bearing 
tumors showed significant accumulation in tumors with minimal targeting of kidney, 
liver and muscles. Tumor-targeting niosomes coated with pHLIP exhibited 2-3 times 
higher tumor uptake compared to the non-targeted niosomes coated with PEG polymer. 
Long circulation time and uniform bio-distribution throughout the entire tumor make 
pHLIP-coated niosomes to be an attractive novel delivery system. 
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Introduction 
 
Most of the currently approved nanomedicinal products for cancer imaging and therapy 
are non-targeted nanovectors that accumulate in the tumor tissues purely through the 
enhanced permeability and retention (EPR) effect (Dawidczyk et al., 2014). It is nearly 
impossible to find a universal targeting moiety for cancers as they are heterogeneous 
(Stingl and Caldas, 2007, Weigelt et al., 2005). At the same time, extracellular acidity 
has been identified as a general property of cancerous cells and especially the most 
aggressive ones (Stubbs et al., 2000, Calorini et al., 2012). Family of pH (Low) Insertion 
Peptides (pHLIP® peptides) are under development as novel agents, which target tumor 
acidity (Andreev et al., 2009, Weerakkody et al., 2013). The peptides sense pH at the 
surface of cancer cells, where it is the lowest (Anderson et al., 2016), and insert into 
cellular membranes (Reshetnyak et al., 2006, Reshetnyak et al., 2007, Reshetnyak et al., 
2008, Andreev et al., 2010). Nanocarriers decorated with pHLIPs are biocompatible, 
can target tumor and demonstrate enhanced cellular uptake by cancer cells (Du et al., 
2014, Wijesinghe et al., 2013, Yao et al., 2013b, Arachchige et al., 2015, Yao et al., 
2013a). In addition to pHLIP-coated nanoparticles, nanocarriers containing pH-
sensitive polymers and lipids were known for decades (Chu et al., 1990, Subbarao et al., 
1987, Karanth and Murthy, 2007, Lee et al., 1998).  
 
In this study we introduced pHLIP-coated niosomes. Niosomes are self-assembled 
bilayer vesicles analogous to liposomes, comprised of surfactants of Span®, Tween® 
or Brij® series (Rajera et al., 2011). Similar to liposomes, niosomes are used to 
encapsulate both hydrophilic and lipophilic drugs. At the same time, non-ionic 
surfactant vesicles, niosomes, are cheaper in production, have longer shelf lives 
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compared to liposomes, and bilayer fluidity and microviscosity could be easily 
modulated (Moghassemi and Hadjizadeh, 2014, Marianecci et al., 2014, Lohumi, 2012, 
Karim et al., 2010). Sorbitan esters (Spans®) are FDA approved for use in food 
processing and pharmaceuticals (Cottrell and van Peij, 2004). They are safe, 
amphiphilic compounds derived from sorbitol (i.e., a synthetic sweetener). Span20 
mostly consists of a fully saturated short alkyl chain (lauryl - C12). The single carbon 
bonds in Span20 allow the alkyl chain to pack tightly, resulting in the smallest and stable 
niosomes, oppose to the niosomes consisting of longer chain surfactants, Spans40-80 
(Lo et al., 2010, Hao et al., 2002, Israelachvili et al., 1980). Vesicles prepared by Span-
series surfactants have been reported to be viable drug carriers for different diseases and 
different routes of administration(Ghanbarzadeh et al., 2015, Balakrishnan et al., 2009, 
Sahoo et al., 2014, Liu et al., 2017, Ammar et al., 2011, Guinedi et al., 2005, Hunter et 
al., 1988, Jadon et al., 2009, Pardakhty et al., 2007). In this study we introduced novel 
formulations, pHLIP-coated niosomes, comprised of Span20 surfactant and cholesterol. 
 
Materials and Methods 
Materials 
Sorbitan monolaurate (Span20); cholesterol ≥ 99%; N-(2-Hydroxyethyl)piperazine-N′-
(2-ethanesulfonic acid) (HEPES) ≥ 99.5% and N-(1-Pyrenyl)maleimide (Pyr-maleimide)  
were purchased from  Sigma-Aldrich. 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] sodium salt (DSPE-
maleimide)  and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[carboxy(polyethylene glycol)-2000] ammonium salt  (DSPE-PEG(2000)) were 
obtained from Avanti Polar Lipids. Octadecyl Rhodamine B chloride (R18) was 
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purchased from Thermo Fisher Scientific. The wild type (WT) pH (Low) Insertion 
Peptide: ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT was prepared by 
solid-phase peptide synthesis and purified at the C.S. Bio. All other chemicals used in 
the study were of the highest purity and all solvents were of spectroscopic grade. Water 
was purified through a Millipore Milli-Q system. 
  
Synthesis of DSPE-pHLIP and Pyr-pHLIP 
pHLIP was conjugated with Pyr-maleimide or DSPE-maleimide in methanol. 5 mg of 
peptide dissolved in 250 µL methanol (blown with argon) and Pyr-maleimide or DSPE-
maleimide (from 9.9 mM stock solution) dissolved in chloroform was mixed at a molar 
ratio 1:1. Reaction mixture was kept at room temperature for about 2-6 hours until the 
conjugation was completed.  The Pyr-pHLIP product formation was monitored by the 
reversed phase (Zorbax SB-C18 columns, 4.6 × 250 mm 5 μm, Agilent Technology) 
high-performance liquid chromatography (RP-HPLC) using a gradient from 25-75% 
acetonitrile in water containing 0.05% trifluoroacetic acid (TFA). The Pyr-pHLIP 
product was characterized by SELDI-TOF mass spectrometry (Pyr-pHLIP expected 
MW 4409.0, found 4401.7, Figure S1). The concentration of Pyr-pHLIP conjugate was 
determined by absorbance using the molar extinction coefficient for Pyr: 339=40,000 
M−1·cm−1. The reaction progress in conjugation of DSPE with pHLIP was monitored 
by the RP-HPLC using a gradient from 25-80% acetonitrile in water containing 0.05% 
TFA by monitoring a decrease of peak corresponding to the unlabeled pHLIP in the 
reaction mixture. The concentration of DSPE-pHLIP conjugate was determined by 
absorbance using the molar extinction coefficient for pHLIP: 280=13,940 M−1·cm−1. 
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Niosomes preparation 
10 mM stock solutions of Span20 and cholesterol were prepared by dissolving the 
products in chloroform and methanol mixture of 3:1 (v/v). pHLIP-coated niosomes were 
prepared by mixing solutions of the 43 mol% of Span20, 50 mol% of cholesterol, 5 mol% 
of DSPE-pHLIP or Pyr-pHLIP and 2 mol% of R18. PEG-coated niasomes were 
prepared by mixing solutions of the 43 mol% of Span20, 50 mol% of cholesterol, 5 mol% 
of DSPE-PEG and 2 mol% of R18. Some preparations of niasomes used for 
fluorescence spectroscopy measurements, hemolysis and plasma stability studies 
contained no R18 and comprised of 45 mol% of Span20, 50 mol% of cholesterol, 5 mol% 
of Pyr-pHLIP, or DSPE-pHLIP, or DSPE-PEG. Solutions containing all components 
were evaporated in the flask covered with aluminum foil for 1 hour on rotary evaporator 
at 60°C producing an even thin film, followed by additional 1 hour evaporation under 
the high vacuum to remove traces of organic solvents. The layers were hydrated in 2 
mL of preheated for 60°C 10 mM PBS or HEPES buffer solutions, pH 7.4 containing 
137 mM NaCl, 2.7 mM KCl and 1 mM CaCl2. To disrupt large particles and obtain 
monodisperse solution of nanoparticles we employed both sonication and extrusion. The 
sonication and extrusion protocols were optimized varying power and duration of 
sonication, as well as adjusting extrusion approach. According to the optimized protocol 
niosome solution was sonicated using the probe sonicator VirTis (VirSonic 100) for 
approximately 5 minutes at 60°C at output power of 8-10 Watts, followed by 
consequential extrusion (31 times) using 200 nm, 100 nm and 50 nm filters. Niosome 
solution was sterilized by filtering through 0.2 μm filter. The concentration was 
calculated by measuring absorbance of R18 at 546 nm (ε546=104,126 M−1 cm−1) or 
pHLIP at 280 nm (ε280=13,940 M−1 cm−1) of the niosomes dissolved in methanol. 
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Niosomes were stored at 4°C. 
 
Size and Zeta potential measurements 
The size distribution of niosomes was measured by dynamic light scattering (DLS) 
using a Zetasizer Nano ZS (Malvern) instrument and a nanoparticle tracking system, 
Nanosight (NS300, Malvern). The zeta ( ) potential was measured on a Zetasizer Nano 
ZS instrument using folded capillary cells from Malvern.  
 
Fluorescence measurements 
Steady-state fluorescence measurements were carried out under a temperature control 
at 25 C on a PC1 spectrofluorometer (ISS, Inc.). The concentration of the pyrene was 
12.5 µM. Pyrene fluorescence was excited at 333 nm and recorded in the range of 350-
500 nm. The polarizers in the excitation and emission paths were set at the “magic” 
angle (54.7o from the vertical orientation) and vertically (0o), respectively.  
 
Cryo-electron microscopy 
Niosome solution (5 μL droplet) was spread on a Lacey formar/carbon electron 
microscopy grid and preserved in a frozen-hydrated state by a rapid freezing in liquid 
ethane. The vitrification process was performed using FEI Vitrobot system with the 
setting of a single blot of 3 sec, an offset of 1, and drain and waiting time of 1 sec. 
Transmission electron microscopy (TEM) (JEOL 2100) with an accelerating voltage of 
200 kV at magnifications in the range of 10,000x to 150,000x was used to image 
niasomes to establish the shape, size, and homogeneity of the particles. Size histograms 
were fitted with a Gauss function. 
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Cell lines 
Lung carcinoma A549 and mouse mammary 4T1 cell lines were obtained from 
American Type Culture Collection (ATCC). Cells were authenticated, stored according 
to the supplier’s instructions, and used within 3 4 months after frozen aliquots 
resuscitations. Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
and Roswell Park Memorial Institute Medium (RPMI) supplemented with 10% fetal 
bovine serum (FBS), 0.1% of 10 μg/mL of ciprofloxacin (Cipro) in a humidified 
atmosphere of 5% CO2 and 95% air at 37°C.  
 
Cell proliferation assay 
A549 and 4T1 cells were seeded in 96 well-plates (~3,000 cells per well) at pH 7.4.  
The following day, cells were treated for 2 hours with increasing concentrations of 
pHLIP-coated niosomes (0, 10, 50, 100, 250, 500 and 1000 μM of Span20) in serum 
free DMEM media at pH 7.4, followed by addition of an equal volume of medium with 
20% (v/v) FBS. In another experiment, after 2 hours of cells treatment with pHLIP-
coated niosomes, the solution was replaced by media containing 10% FBS. Cells were 
grown for 3 days until non-treated cells in control reached 80 90% confluence. Cell 
viability was assessed by the colorimetric reagent (CellTiter 96 AQueousOne Solution 
Assay, Promega) of the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay, which was added 
for 1 hour to cells followed by measuring absorbance at 490 nm. All samples were 
prepared in triplicate. Each experiment was repeated several times. 
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Hemolysis assay 
Single donor human whole blood was purchased from Innovative Research. Red blood 
cells (RBCs) were collected by centrifugation of whole blood at 2000 rpm for 10 
minutes followed by washing three times with Dulbecco’s PBS (DPBS) and re-
suspended in DPBS at a concentration of 7.5% (v:v). Varying concentrations of 
niosomes (from 50 µM up to 400 µM)  in 10 mM HEPES buffer, pH 7.4 containing 
137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 were added to RBCs to form 5% RBC 
suspension. The resultant mixtures were incubated at 37°C for 2 hours and then 
centrifuged at 2000 rpm for 10 min. The hemolysis was assessed by the release of 
hemoglobin, which was monitored by measuring of absorbance at 450 nm. 10 mM 
HEPES buffer, pH 7.4 containing 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 and DPBS 
were used as negative controls. As positive controls, which result in 100% lysis of RBCs, 
we used i) water and ii) 10% of Triton X-100. The percentage of hemolysis was 
calculated as follows:  
 
% 𝐻𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 = 100 ∙
𝑂𝐷𝑇𝑒𝑠𝑡 − 𝑂𝐷𝑁𝐶
𝑂𝐷𝑃𝐶 − 𝑂𝐷𝑁𝐶
 
 
where, ODTest, ODNC, and ODPC are the optical density reading (absorbance) values 
of the test sample, negative control and positive control, respectively. The assay was 
performed in triplicate on niosomes with and without R18. 
 
Stability in plasma 
Plasma was separated from the single donor human whole blood by centrifugation of 
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whole blood at 2000 rpm for 10 minutes and collecting of supernatant. Varying 
concentrations of niosomes (from 50 µM up to 400 µM) in 10 mM HEPES buffer, pH 
7.4 containing 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 were added to plasma and 
incubated at 37°C. The stability of niosomes was assessed by monitoring size of 
niosomes measured using a nanoparticle tracking system, Nanosight (NS300, Malvern) 
before mixing with plasma and at 0, 2 and 24 hours after the treatment with plasma.  
 
Cellular uptake of niosomes 
A549 and 4T1 cells (~500,000 cells) in suspension were treated with 500 µM R18 
labelled pHLIP-coated niosomes at pH 7.8 and pH 5.5 for about 1 hour at 37°C in serum 
free DMEM media. We used DMEM containing no sodium bicarbonate and adjusted 
pH by HCl or NaOH. After incubation period, cells were pelleted by centrifugation 
(2500 rpm, 2.5 min) at room temperature. The supernatant was removed and the cell 
pellet was re-suspended in 1 mL of fresh PBS pH 7.4 and centrifuged for the second 
time. The second cell pellet was re-suspended in PBS pH 7.4 with or without addition 
of Trypan Blue solution (Sigma-Aldrich). The 20 μL of the cell suspension solution was 
loaded into a counting chamber. The cellular uptake of fluorescent niosomes was 
assessed by counting of fluorescent cells using Nexcelom cellometer at 525 nm 
excitation and 595 nm emission channels.  
 
Fluorescence microscopy 
In separate experiment, A549 and 4T1 cells (~500,000 cells) in suspension were treated 
with 500 µM R18 labelled pHLIP-coated niosomes at pH 6.4 (or normal pH 7.4) for 1 
hour at 37°C serum free media and followed by the described above steps of cell 
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washing. After washing, the cell pellet was re-suspended and cells were seeded in glass 
bottom collagen coated cell dishes (MatTek). The phase contrast and fluorescence 
images from cells were recorded at 0, 4 and 24 hours under an inverted epi-fluorescence 
microscope (Olympus IX71) using a 20x and 40x objective lenses. 
 
Tumor mouse model 
All animal studies were conducted according to the animal protocol AN07-01-015 
approved by the Institutional Animal Care and Use Committee at the University of 
Rhode Island, in compliance with the principles and procedures outlined by NIH for the 
Care and Use of Animals. 4T1 mammary tumors were established by subcutaneous 
injection of 4T1 cells (1 × 106 cells/mL, 0.1 mL/flank) in the right flank of adult female 
BALB/c mice (about 20 25 g weight) obtained from Envigo RMS, Inc. For this study, 
34 mice were used including controls.  
 
Ex vivo fluorescence imaging 
When tumors reached 6 8 mm in diameter different constructs of niosomes containing 
2 mol% of fluorescent R18 were given as a single tail vein injection (100 µL of 50 µM 
of R18). Animals were euthanized at 4, 24 and 48 hours post-injection. Necropsy was 
performed immediately after euthanization. The Supplementary Tables S1 and S2 
contain information about the number of animals used for each fluorescently-labeled 
niosomes for each time point. Tumors, kidneys, liver and muscles were collected for 
imaging on a FX Kodak in-vivo image station connected to the Andor CCD. The 
imaging was performed using excitation and emission filters with a band of 
transmittance at 540±20 nm and 605±20 nm, respectively. The mean fluorescence 
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intensities of tumor and organs were calculated using ImageJ software.     
 
Imaging of tumor sections 
Frozen tumor tissues were sectioned at a thickness of 5 μm using a Vibratome UltraPro 
5000 Cryostat. Sections were mounted on microscope slides, dried in air, and washed 
with deionized water. Tumor sections mounted on microscopic slides were directly 
incubated with 1 mM DAPI solution in PBS at 37°C for about 10 minutes and washed 
with PBS solution to remove excess of the dye. Frozen tumor sections with R18 
contained pHLIP-coated niosomes were analyzed without further processing using 
Zeiss LSM 700 confocal module under DAPI and Rhodamine channels using a 20x 
objective lens. Following fluorescence imaging, the adjacent sections were then stained 
with hematoxylin and eosin (H&E) and imaged under microscope. 
 
Results 
We introduced two formulations of pHLIP coated niosomes. In both cases the major 
components of niosome content was Span20 (varied in the range of 43 45 mol%) and 
cholesterol (50 mol%), and in some niosome formulations we also used fluorescent R18 
(0-2 mol%). pHLIP was conjugated either with DSPE lipids (DSPE-pHLIP) or 
hydrophobic fluorescent dye, pyrene, (Pyr-pHLIP) and introduced into niosomes at 
amount of 5 mol%. These formulations represent two different approaches for 
introducing pHLIP into niosome coating: i) pHLIP conjugated with the lipid headgroup 
as it was done previously (Wijesinghe et al., 2013) and ii) pHLIP conjugated to various 
hydrophobic molecules, such as pyrene, which have high affinity to membrane and can 
intercalate into bilayer. There is an advantage of using pyrene over DSPE lipids, since 
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i) progression of conjugation reaction of pHLIP with pyrene is easy to monitor by HPLC 
and mass-spectrometry; ii) incorporation of Pyr-pHLIP into niosomes could be assessed 
by measuring changes of pyrene fluorescence (see below); and iii) pyrene could be used 
for intercalation into bilayers of various thicknesses.  
 
The cryo-TEM imaging confirmed unilamellar structure of pHLIP-coated niosomes 
(Figure 1a, b). The multiple cryo-TEM images were analyzed to plot size-distribution 
histograms, which were fitted by Gauss functions (Figure S2). The mean and standard 
deviations of Gaussian distributions for DSPE-pHLIP and Pyr-pHLIP coated niosomes 
were established to be 65.2±15.3 nm and 52.2±10.1 nm, respectively (Table 1). The 
hydrodynamic diameter of DSPE-pHLIP and Pyr-pHLIP coated niosomes in solution 
were 89.7±7.1 nm and 72.6±3.3 nm, respectively. The zeta potential of DSPE-pHLIP 
and Pyr-pHLIP coated niosomes was -35.4 mV and -31.3 mV, respectively. When Pyr-
pHLIP was incorporated into niosomes the fluorescence spectra of pyrene was altered 
compared to the pyrene emission in methanol (the niosome formulation used for 
fluorescence measurements did not contain fluorescent R18) (Figure 1c). It was 
observed appearance of the characteristic excimer fluorescence at 440-500 nm, which 
is indicative of the stacking of pyrene rings within the bilayer of niosomes.  
 
We investigated shelf lifetime of pHLIP coated niosomes. The formulations were kept 
in buffer solution of pH 7.4 refrigerated at 4°C for a month. The size of particles 
remained unchanged in solution during 30 days, while the values of zeta potential 
decreased on about 40% (from negative 30 35 mV to negative 47 53 mV) (Figure 
S3). The changes of zeta potential, which were not associated with changes of particle 
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size, might be attributed to the oxidation of the components of Span20 mixture forming 
negatively charged species and enhancing an overall negative charge of niosomes (de 
Sousa Lobato et al., 2013, Kishore et al., 2011, Smith, 1981, Kerwin, 2008). 
 
The cytotoxicity of the pHLIP-coated niosomes was tested on murine 4T1 mammary 
cancer cells and human lung A549 carcinoma cells. The data indicate that DSPE-pHLIP 
and Pyr-pHLIP niosomes do not show toxicity for cells. The pH-dependent cellular 
uptake of the fluorescent pHLIP-coated niosomes containing 2 mol% of R18 was 
assessed by quantifying rhodamine fluorescence taken by cells. Cells were treated with 
R18 containing niosomes at pH 7.8 and pH 5.5 for 1 hour. We choose to treat cells with 
constructs at pH7.8, which is slightly above than normal physiological pH7.4, since it 
was shown that pH at the surface of cancer cells, especially highly metastatic cancer 
cells such as 4T1, is lower even when pH of media is normal (Anderson et al., 2016). 
We also choose to treat cells with constructs at pH5.5, which is slightly lower than mean 
pH established at the surface of cancer cells within tumors, pH6.0, (Anderson et al., 
2016) with main goal to enhance difference in cellular uptake of niosomes in this model 
experiment. The fluorescent signal from the cells treated with niosomes was analyzed 
using cellometer (Figure 2). We also used cell impermeable dye, Trypan Blue, to quench 
fluorescent signal outside of cells or at the outer leaflet of lipid bilayer of plasma 
membrane to prove that fluorescent signal is associated with cellular uptake of niosomes. 
It is known that Trypan Blue is used to quench fluorescence in the range of 580 620 nm 
(Nuutila and Lilius, 2005). The uptake of the fluorescent niosomes coated with both 
DSPE-pHLIP and Pyr-pHLIP by 4T1 and A549 cancer cells was from 2 to 9 times 
higher at low pH compared to the uptake at treatment pH of 7.8 (established with high 
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statistical significance, p-levels determined by the two-tailed unpaired Student’s t-test 
were less than 0.0001). Addition of Trypan Blue to cells led to the quenching of 
rhodamine fluorescence. More detailed information about cellular fluorescence after the 
treatment with niosomes is presented in Figure S4.  
 
Next, we investigated distribution of the fluorescent niosomes within A549 and 4T1 
cancer cells. Cells were treated with R18 fluorescent niosomes at low pH (pH6.4) for 1 
hour, followed by washing, seeding cells in glass bottom collagen coated cell dishes and 
imaging. The fluorescent signal of DSPE-pHLIP and Pyr-pHLIP coated niosomes in 
A549 cells (Figure 3) and 4T1 cells (Figure S5) were distributed through cells, most 
probably in endosomes and lysosomes. The data confirmed pH-dependent cellular 
uptake of pHLIP-coated niosomes. 
 
Finally, our goal was to investigate tumor targeting and distribution of pHLIP-coated 
niosomes, which we compared with the control niosomes coated with PEG polymer that 
accumulate in tumors due to the EPR effect. Before proceeding to animal studies we 
investigate stability of pHLIP and PEG coated niosome formulations in plasma, and 
calculated percentage of hemolysis. RBCs and plasma were separated from human 
blood samples. RBCs were treated with two sets of increasing concentrations of pHLIP 
and PEG coated niosomes with and without R18 for 2 hours at 37°C. The lysis of RBCs 
was less than 1% in the case of use of DSPE-pHLIP and Pyr-pHLIP coated niosomes 
and less than 2% for DSPE-PEG coated niosomes.  Also, stability of pHLIP and PEG 
coated niosomes with and without R18 were investigated for 24 hours in plasma 
separated from the blood. The size of all niosome formulations (DSPE-pHLIP, Pyr-
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pHLIP and DSPE-PEG) was not altered indicating on their stability in blood. 
 
The tumor targeting of the fluorescent R18 containing DSPE-pHLIP and Pyr-pHLIP 
coated niosomes were investigated in mice. Fluorescent niosomes were given as a single 
tail vein injection, animals were euthanized at different time points post-injection (4, 24 
and 48 hours). Main organs were collected, cut in half and imaged (Figure 4 and Table 
S1). At 24 hours we observed peak in tumor uptake of the fluorescent niosomes. The 
mean tumor to muscle ratio within 48 hours was found to be 4.9±1.3 and 6.8±1.4 for 
DSPE-pHLIP and Pyr-pHLIP coated niosomes, respectively. The signal in kidney was 
minimal, with some accumulation of the constructs in liver. Uptake of pHLIP-coated 
niosomes by tumor, muscle, kidney and liver at 24 hours post-injection was compared 
with the uptake of PEG-coated niosomes. Figure 5a shows representative images of 
tumor and organs obtained from mice injected with different constructs and Figure 5b 
(and Table S2) reflects quantitative uptake of the constructs by the tumors and organs. 
Tumor-targeting niosomes coated with pHLIP exhibited 2.1-2.7 times higher tumor 
uptake compared to the non-targeted niosomes coated with PEG polymer. Figure 6 
demonstrates cellular distribution of fluorescent signal within the tumor mass. The 
sections were obtained from the center of the tumors. The fluorescence is associated 
with cellular structures and no nuclear staining was observed as in the case of 
experiments on cultured cells. 
 
Discussion  
The targeted delivery of nanomaterials is one of the most important aspects of successful 
development of nanotechnology and translation of nanomaterials to the clinics. Various 
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approaches are tested with moderate success. Our approach is based on targeting of 
tumor acidity by utilizing ability of pHLIPs to sense pH at the surface of cells. Acidosis 
is a general property of tumor microenvironment associated with tumor development 
and progressions (Fang et al., 2008, Gillies et al., 2008, Vander Heiden et al., 2009). 
Moreover, acidity is linked to other pathological states, such as ischemia, atherosclerosis, 
stroke (Rajamäki et al., 2013, Koo et al., 1993, Mizock and Falk, 1992). It was shown 
that nanoparticles coated with pHLIP promote targeting and cellular uptake of these 
nanoparticles (Wijesinghe et al., 2013, Yao et al., 2013b, Yao et al., 2013a, Wei et al., 
2017, Janic et al., 2016, Tian et al., 2017, Emmetiere et al., Han et al., 2013, Yu et al., 
2016, Yu et al., 2015). Previously, we demonstrated that pHLIP-coated liposomes 
capable to fuse with cellular membranes and promote delivery hydrophobic cargo 
molecules to cellular membranes, and hydrophilic payloads to cytoplasm of cancer cells 
(Yao et al., 2013b). In this work we tested surfactant- and cholesterol-based niosomes. 
The pHLIP-coated niosomes were smaller in size and more stable compared to the 
pHLIP-coated liposomes. pHLIP-coated niosomes demonstrated pH-dependent cellular 
uptake and excellent tumor targeting. Control non-targeted PEG-coated niosomes 
exhibited 2-3 times less tumor accumulation. Targeting of acidic tumors occurs due to 
the ability of pHLIPs to insert into cellular membranes in environment of low 
extracellular pH. Thus, at low pH, pHLIPs behave as fusogenic peptides, which bring 
the niosome membrane in close contact to the cellular membrane. There are two main 
possibilities of pHLIP-coated niosome’s cellular entry. Either pHLIP-coated niosomes 
might fuse directly with the plasma membrane of cancer cells in environment of low pH 
and/or niosomes can be taken up into the cell via endocytotic pathways, more favorably, 
via micropinocytosis due simultaneous insertions of multiple pHLIPs into the cellular 
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membrane. Niosomes, which are internalized into cell via endocytosis might fuse with 
the endosomal membrane at low pH. In either case, niosomes carrying lipophilic and/or 
hydrophilic drugs can effectively enter into the cells in a pH-dependent manner.  
 
The pHLIP-coated liposomes and niosomes follow a closely similar mechanism utilized 
by viruses and pathogenic organisms to enter into a cell. In contrast to liposomes, 
niosomes are smaller in size, they demonstrate prolong shelf life, very good tumor 
targeting and distribution within tumor, and their manufacturing cost is lower. On other 
hand, niosome’s encapsulation capacity is lower and different combinations of 
surfactants are needed for entrapment of various hydrophobic molecules within their 
bilayer to preserve overall stability of nano-vesicles. Different formulations might find 
utility for different therapeutic purposes.  
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TABLES 
 
Table 1. The center of Gauss distribution (DTEM) and the standard deviation obtained 
after fitting of histograms of niosome’s diameter distributions (shown on Figure S2) 
calculated by analyzing cryo-TEM images. The mean hydrodynamic diameter (Dh), the 
zeta potential ( ) and the polydispersity index (PDI) were obtained from the dynamic 
light scattering measurements performed on niosomes in HEPES buffer at pH 7.4. 
DSPE-pHLIP and Pyr-pHLIP (5 mol%) coated Span20 (45 mol%) and cholesterol (50 
mol%) niosomes were used. 
 
 
 
Construct DTEM, nm Dh, nm , mV PDI 
DSPE-pHLIP 65.2 ± 15.3 89.7 ± 7.1 -35.4 ± 2.3 0.19 ± 0.01 
Pyr-pHLIP 52.2 ± 10.1 72.6 ± 3.3 -31.3 ± 1.7 0.25 ± 0.01 
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FIGURES 
 
 
Figure 1. Cryogenic TEM image of the a) DSPE-pHLIP (5 mol%) and b) Pyr-pHLIP 
(5 mol%) coated Span20 (45 mol%) and cholesterol (50 mol%) niosomes. The images 
are obtained at 25,000x magnification. c) The fluorescence spectra of Pyr-pHLIP 
measured in methanol and Pyr-pHLIP incorporated in niosomes. 
68  
 
Figure 2. Normalized uptake of DSPE-pHLIP (5 mol%) and Pyr-pHLIP (5 mol%) coated 
Span20 (43 mol%) and cholesterol (50 mol%) niosomes containing 2 mol% of fluorescent R18 
by 4T1 mammary (a) and A549 lung (b) cancer cells at pH 7.8 and pH 5.5 before (magenta 
columns) and after (gray columns) treatment with Trypan blue. The fluorescent signals were 
normalized by the rhodamine fluorescence intensity of 4T1 cells at pH 7.8 treated with DSPE-
pHLIP before addition of Trypan blue. Statistically significant differences were determined by 
two-tailed unpaired Student’s t-test, only statistically non-significant differences are indicated 
(ns means p-level > 0.05), all other differences in cellular uptake calculated at different pHs, as 
well as before and after Trypan Blue addition are statistically significant (p-level is less than 
0.0001 in each case). The distribution of fluorescent signal in cells is presented in Figure S4. 
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Figure 3. Uptake and cellular distribution of a-d) DSPE-pHLIP (5 mol%) and e-h) Pyr-
70  
pHLIP (5 mol%) coated Span20 (43 mol%) and cholesterol (50 mol%) niosomes 
containing 2 mol% of fluorescent R18 by A549 lung cancer cells. Cells were treated 
with fluorescence niosomes at pH 6.4 for 1 hour, followed by washing, seeding cells in 
glass bottom collagen coated cell dishes and imaging at next day. Fluorescence (a, b, e, 
f) and phase contrast (c, d, g, h) images were obtained using 20x (a, c, e, g) and 40x (b, 
d, f, h) magnification objective lenses. 
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Figure 4. Time-dependent distribution of DSPE-pHLIP and Pyr-pHLIP (5 mol%), 
Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes in a) tumor, b) 
muscle, c) kidney and d) liver at 4, 24 and 48 hours after single I.V. administration of 
the constructs. Tumor/Muscle (T/M), Tumor/Kidney (T/K) and Tumor/Liver (T/L) ratio 
calculated for DSPE-pHLIP (e) and Pyr-pHLIP (f) niasomes are shown. The values of 
mean surface fluorescence intensity of R18 in tissue and organs are presented in Table 
S1. 
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Figure 5. a) The representative rhodamine fluorescence images and b) mean surface 
fluorescence of tumor (cut in half), muscle, kidney (cut in half) and liver obtained by ex 
vivo imaging after collection of organs and tissues 24 hours after I.V. administration of 
pHLIP and PEG coated niosomes are shown (the autofluorescence signal is subtracted). 
The color coded fluorescent images shown on panel a are obtained at the same settings 
of the imaging instrument, the same exposure time (15 sec), and all of them were 
processed exactly the same way. Control means organs collected from the mouse with 
no injection of fluorescent niosomes, and it represents level of auto fluorescence signals 
in tissue. The values of mean surface fluorescence intensity of R18 in tissue and organs 
are presented in Table S2. 
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Figure 6. Distribution of R18 fluorescent signal in tumor sections obtained at 24 hours 
after I.V. injection of a-d) DSPE-pHLIP (5 mol%) and e-h) Pyr-pHLIP (5 mol%) coated 
Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes. The rhodamine 
fluorescence (a, e), cell nucleus stained with DAPI (b, f), the overlay of rhodamine and 
DAPI fluorescence (c, g), and adjacent HE stained sections from the same tumor (d, h) 
are shown.
75  
SUPPLEMENTARY INFORMATION 
 
 
 
pH-sensitive pHLIP® Coated Niosomes 
 
 
 
Mohan C. Pereira1, Monica Pianella2, Da Wei1, Anna Moshnikova1, 
Carlotta Marianecci2, Maria Carafa2, Oleg A. Andreev1, Yana K. Reshetnyak1 
 
 
 
 
 
 
 
 
1Physics Department, University of Rhode Island, 2 Lippitt Rd., Kingston, RI 02881, 
USA 
 2Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, 
P.zzle A. Moro 5 00185 Roma, Italia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76  
Table S1. The mean and standard error values of the surface fluorescence 
intensity of R18 in tissue and organs at different time points after single I.V. 
administration of the DSPE-pHLIP or Pyr-pHLIP (5 mol%), Span20 (43 
mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes. The 
autofluorescence signal, which was in the range of 200-250 was subtracted.  
 
 Time 
DSPE-pHLIP 
n=3 
Pyr-pHLIP 
n=3 
Tumor 4 h 447 ± 84 498 ± 232 
 24 h 1870 ± 153 2409 ± 334 
 48 h 1401 ± 209 1562 ± 194 
Muscle 4 h 76 ± 34 94 ± 44 
 24 h 337 ± 40 297 ± 7 
 48 h 410 ± 80 223 ± 35 
Kidney 4 h 134 ± 34 207 ± 55 
 24 h 370 ± 60 255 ± 22 
 48 h 384 ± 54 225 ± 20 
Liver 4 h 446 ± 133 417 ± 154 
 24 h 1020 ± 225 893 ± 195 
 48 h 1343 ± 388 482 ± 52 
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Table S2.  The mean and standard error values of the surface fluorescence 
intensity of R18 in tissue and organs at 24 hours after single I.V. 
administration of different formulations of niosomes: DSPE-PEG, DSPE-
pHLIP or Pyr-pHLIP (5 mol%), Span20 (43 mol%), cholesterol (50 mol%) 
and R18 (2 mol%) niosomes. 
 
 
DSPE-PEG 
n=4 
DSPE-pHLIP 
n=3 
Pyr-pHLIP 
n=3 
Tumor 889 ± 191 1870 ± 153 2409 ± 334 
Muscle 173 ± 38 337 ± 40 297 ± 7 
Kidney 187 ± 43 370 ± 60 255 ± 22 
Liver 343 ± 97 1020 ± 225 893 ± 195 
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Figures 
 
 
 
Figure S1. The SELDI-TOF mass spectrum of Pyr-pHLIP. 
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Figure S2. The size histograms of the DSPE-pHLIP and Pyr-pHLIP 
containing niosomes obtained after analyzing multiple cryo-TEM images. 
The red lines demonstrate fittings by Gauss functions. 
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Figure S3. The results of stability study of DSPE-pHLIP and Pyr-pHLIP (5 
mol%), Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%) 
niosomes in HEPES buffer in a course of 30 days (niosomes were kept 
refrigerated at 4°C). The changes of mean hydrodynamic diameter and Zeta 
potential are presented. 
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Figure S4. Fluorescent uptake of DSPE-pHLIP or Pyr-pHLIP (5 mol%), 
Span20 (43 mol%) and cholesterol (50 mol%) niosomes containing 2 mol% 
of fluorescent R18 by 4T1 mammary and A549 lung cancer cells at pH 7.8 
and pH 5.5 before and after treatment with Trypan blue. The cellular uptake 
of fluorescent niosomes was assessed by counting of fluorescent cells using 
cellometer at 525 nm excitation and 595 nm emission channels. 
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Figure S5. Uptake and cellular distribution of a-d) DSPE-pHLIP (5 mol%) 
and e-h) Pyr-pHLIP (5 mol%) coated Span20 (43 mol%) and cholesterol (50 
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mol%) niosomes containing 2 mol% of fluorescent R18 by 4T1 lung cancer 
cells. Cells were treated with fluorescence niosomes at pH 6.4 for 1 hour, 
followed by washing, seeding cells in glass bottom collagen coated cell 
dishes and imaging at next day. Fluorescence (a, b, e, f) and phase contrast 
(c, d, g, h) images were obtained using 20x (a, c, e, g) and 40x (b, d, f, h) 
magnification objective lenses. 
 
